Lindsay J. Caverly

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell et al. · The Lancet Respiratory Medicine · 2022 · 116 citations · Full text

Medicine, Hypertonic Saline, Dornase Alfa +1

Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis

Lisa A. Carmody, Lindsay J. Caverly, Bridget K. Foster et al. · PLoS ONE · 2018 · 94 citations · Full text

Dysbiosis, Inflammatory Lung Disease, Antibiotics +14

Mycobacterium abscessus Induces a Limited Pattern of Neutrophil Activation That Promotes Pathogen Survival

Kenneth C. Malcolm, E. Michelle Nichols, Silvia M. Caceres et al. · PLoS ONE · 2013 · 66 citations · Full text

Immunology, Bacteriology, Bacterial Pathogenesis +17

Mycobacterium abscessus Morphotype Comparison in a Murine Model

Lindsay J. Caverly, Silvia M. Caceres, Cori Fratelli et al. · PLoS ONE · 2015 · 49 citations · Full text

Medical Microbiology, Pathogenic Microbiology, Inflammatory Lung Disease +14

Effects of azithromycin in Pseudomonas aeruginosa burn wound infection

David P. Nichols, Silvia M. Caceres, Lindsay J. Caverly et al. · Journal of Surgical Research · 2013 · 46 citations · Full text

Burn Wound Infection, Antibiotics, Wound Care +7